BEAM
Price
$20.99
Change
-$0.93 (-4.24%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.13B
104 days until earnings call
Intraday BUY SELL Signals
RLAY
Price
$6.36
Change
-$0.15 (-2.30%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.13B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs RLAY

Header iconBEAM vs RLAY Comparison
Open Charts BEAM vs RLAYBanner chart's image
Beam Therapeutics
Price$20.99
Change-$0.93 (-4.24%)
Volume$17.49K
Capitalization2.13B
Relay Therapeutics
Price$6.36
Change-$0.15 (-2.30%)
Volume$39.09K
Capitalization1.13B
BEAM vs RLAY Comparison Chart in %
BEAM
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BEAM vs. RLAY commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and RLAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BEAM: $21.94 vs. RLAY: $6.51)
Brand notoriety: BEAM and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 64% vs. RLAY: 117%
Market capitalization -- BEAM: $2.13B vs. RLAY: $1.1B
BEAM [@Biotechnology] is valued at $2.13B. RLAY’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and RLAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 8 bearish.
  • RLAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -2.40% price change this week, while RLAY (@Biotechnology) price change was +3.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

RLAY is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.13B) has a higher market cap than RLAY($1.13B). RLAY YTD gains are higher at: 58.010 vs. BEAM (-11.532). RLAY has higher annual earnings (EBITDA): -338.15M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. RLAY (657M). RLAY has less debt than BEAM: RLAY (34.2M) vs BEAM (155M). BEAM has higher revenues than RLAY: BEAM (60.3M) vs RLAY (8.36M).
BEAMRLAYBEAM / RLAY
Capitalization2.13B1.13B189%
EBITDA-414.33M-338.15M123%
Gain YTD-11.53258.010-20%
P/E RatioN/AN/A-
Revenue60.3M8.36M722%
Total Cash1.15B657M175%
Total Debt155M34.2M453%
TECHNICAL ANALYSIS
Technical Analysis
BEAMRLAY
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHGEX13.17N/A
N/A
JHancock Global Equity A
NIECX19.11N/A
N/A
BNY Mellon International Equity C
JVAAX38.76N/A
N/A
JPMorgan Value Advantage A
MRAEX13.07N/A
N/A
Meridian Hedged Equity A
BIECX26.45-0.18
-0.68%
Brandes International Equity C

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with NRIX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-1.66%
NRIX - RLAY
55%
Loosely correlated
-1.02%
IMNM - RLAY
53%
Loosely correlated
-1.49%
BDTX - RLAY
53%
Loosely correlated
-1.12%
CRNX - RLAY
52%
Loosely correlated
-1.17%
BEAM - RLAY
50%
Loosely correlated
-0.36%
More